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Type I interferons (IFN-I) are essential antiviral cyto-
kines produced upon microbial infection. IFN-I elicits
this activity through the upregulation of hundreds
of IFN-I-stimulated genes (ISGs). The full breadth of
ISG induction demands activation of a number of
cellular factors including the IkB kinase epsilon
(IKKε). However, the mechanism of IKKε activation
upon IFN receptor signaling has remained elusive.
Here we show that TRIM6, a member of the E3-ubiq-
uitin ligase tripartite motif (TRIM) family of proteins,
interacted with IKKε and promoted induction of
IKKε-dependent ISGs. TRIM6 and the E2-ubiquitin
conjugase UbE2K cooperated in the synthesis of
unanchored K48-linked polyubiquitin chains, which
activated IKKε for subsequent STAT1 phosphoryla-
tion. Our work attributes a previously unrecognized
activating role of K48-linked unanchored polyubiqui-
tin chains in kinase activation and identifies the
UbE2K-TRIM6-ubiquitin axis as critical for IFN sig-
naling and antiviral response.
INTRODUCTION
Innate immune signaling pathways are activated when path-
ogen-associated molecular patterns (PAMPs) contained in
microbial products are recognized by host cell pattern-recogni-
tion receptors (PRRs) such as Toll-like receptors (TLRs) and
RIG-I-like receptors (RLRs) (Medzhitov et al., 1997; Meylan
et al., 2006). Activation of these pathways ultimately results in
production of type I interferons (IFN-I) and other cytokines
essential for an effective antimicrobial response (Akira et al.,
2006). Different adaptor proteins function to transmit down-880 Immunity 40, 880–895, June 19, 2014 ª2014 Elsevier Inc.stream signals converging at the point of the IkB (IKK) and
IKK-related kinases (Kawai et al., 2005; Yamamoto et al.,
2003). The IKK-related kinases (TBK1 and IKKε) phosphorylate
the transcription factors IRF3 and IRF7 required for type I IFN
production (Hemmi et al., 2004; Sharma et al., 2003).
IFN-I receptor-mediated signaling triggers phosphorylation of
signal transducers and activators of transcription 1 (STAT1) and
STAT2. Together, STAT1, STAT2, and a third transcription fac-
tor, IRF9, form the Interferon Stimulated Gene Factor 3 (ISGF3)
complex, which is essential for induction of many IFN-stimulated
genes (ISGs) (Platanias, 2005). The tyrosine kinases JAK1 and
TYK2 are critical for phosphorylation of tyrosine 701 (Y701) on
STAT1 and its subsequent induction of a broad range of ISGs
(Shuai et al., 1993). In addition to tyrosine phosphorylation,
S708 has also been reported to modulate the transcriptional
potential of STAT1 and is required for establishing an effective
antiviral state (Tenoever et al., 2007). S708 is phosphorylated
by IKKε during IFN signaling, but the mechanism by how IKKε
becomes activated has remained elusive (Tenoever et al., 2007).
Ubiquitination of proteins is an important posttranslational
covalent modification process that has been thoroughly demon-
strated to regulate signaling pathways in immune regulation and
cytokine production (Jiang and Chen, 2012). Ubiquitin (Ub), a 76
amino acid protein, has 7 lysines, each of which can be conju-
gated by another Ub to form a poly-Ub chain (Trempe, 2011). It
is generally accepted that proteins covalently attached to poly-
Ub chains linked through lysine 48 (K48) of Ub are targeted for
degradation by the proteasome. Conversely, protein modifica-
tion with K63-linked poly-Ub chains has nonproteolytic acti-
vating functions (Chen and Sun, 2009).
The TRIM family of proteins, which are characterized by the
presence of a RING, B box, and a coiled-coil domain, has
been implicated in innate immune signaling pathways by acting
as E3-Ub ligases (Rajsbaum et al., 2014). Recently, we have
shown that an unprecedented large number of TRIMs positively
regulates innate immune responses (Versteeg et al., 2013); how-
ever, only a limited number of these TRIMs that act as positive
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report that TRIM6 together with the E2 Ub conjugase UbE2K
synthetizes unanchored K48-linked poly-Ub chains that activate
IKKε to phosphorylate STAT1 S708, ultimately resulting in the in-
duction of a subset of ISGs essential for the antiviral response
in vitro and in vivo.
RESULTS
TRIM6 Plays a Role in Induction of IFN-b and ISGs but
Not of NF-kB-Dependent Cytokines
We and others have recently reported that a large number of
TRIMs are able to positively enhance innate immune signaling
pathways (Versteeg et al., 2013; Uchil et al., 2013). TRIM6, which
had thus far remained completely uncharacterized in immune
regulation, was identified as a positive regulator of the type I
IFN axis in our screen (Versteeg et al., 2013). We therefore set
out to investigate the role of TRIM6 in the activation of these
innate immune pathways.
First, the ability of TRIM6 to enhance RIG-I-mediated activa-
tion of IFN- and NF-kB-responsive promoters was investigated
(Figures 1A, 1B, and Figure S1A available online). Exogenous
TRIM6 expression enhanced the Sendai virus (SeV)- and the
constitutively active RIG-I(2CARD)-dependent IFN response
in a dose-dependent manner (Figure 1A). In contrast, RIG-
I(2CARD)-dependent induction of the NF-kB promoter was
minimally affected as compared to TRIM25, which has been pre-
viously reported to enhance RIG-I-dependent NF-kB activation
(Figure 1A; Gack et al., 2007). These results suggest that
TRIM6 is a positive regulator of the IFN-b pathway acting down-
stream of MAVS/IPS-1 toward the TBK-1 and IKKε signaling axis
(Figure S1A). Accordingly, TRIM6 also enhanced TBK-1- and
IKKε-dependent IFN induction (Figure 1B).
To further validate these results, we performed loss-of-
function experiments by silencing TRIM6 expression with
short-hairpin lentiviral vector pools (shRNA) in primary human
monocyte-derived dendritic cells (hDCs) from four different
healthy human donors (Figure S1B). TRIM6 mRNA expression
was consistently reduced more than 80% in TRIM6-silenced
(TRIM6si) hDCs (Figures 1C and S1C). At early time points after
TLR4 activation by LPS (2 hr p.t.), IFN-b, ISG54, TNF-a, IL-6,
and IL-8 mRNA levels were induced about 10- to 80-fold in con-
trol cells compared to mock-treated samples (Figures 1D and
S1D). Strikingly, although IFN-b and ISG54 mRNA levels were
attenuated in TRIM6si hDCs as compared to control cells, IL-6
and IL-8 levels were not affected and in some cases even
increased (Figures 1E and S1E). These data indicate that
TRIM6 specifically acts as a positive regulator of the IFN system,
yet does not play a role in promoting induction of proinflamma-
tory cytokines.
Next, we set out to establish the importance of TRIM6 for
mounting a cytokine response during virus infections. To this
end, TRIM6 was silenced in lung epithelial A549 cells by short
interfering RNA (siRNA) and subsequently analyzed for cytokine
and ISG induction upon SeV or influenza A virus (IAV; PR8 strain)
infection (Figure 2). TRIM6was silenced bymore than 75%at the
mRNA (Figures 2A and S2A) and protein (Figure S2B) levels. SeV
and IAV infection strongly induced IFN-b induction—albeit with
different kinetics—which was attenuated by TRIM6si without aneffect on proinflammatory TNF-a expression (Figure 2B). ISGs
including RIG-I, OAS1, MxA, and ISG54 were all reduced
by TRIM6si (Figure 2C), whereas viral RNA replication was
increased (Figure 2D). Together, these data demonstrate that
TRIM6 is required for efficient IFN and ISG induction and that
its depletion impairs the antiviral response as a result of attenu-
ated IFN-I signaling, a phenotype reminiscent of that described
for IKKε-deficient mice (Tenoever et al., 2007).
Immunoblot analyses showed that phosporylation of IRF3 and
IKKε (a hallmark of activation) was reduced in TRIM6si cells upon
infection with wild-type (WT) IAV or a recombinant virus (R38A/
K41A) unable to effectively antagonize IFN induction (Figure 2E;
Talon et al., 2000). The effect of TRIM6was not specific for RIG-I-
induced IFN-b induction, as shown by the fact that TRIM6si also
attentuated poly(I:C)-induced IFN-b and ISG54 mRNA expres-
sion (Figure 2F), as well as secreted IFN-b protein (Figure S2C)
through MDA5. Consequently, the lower amounts of IFN-b pro-
duction observed in TRIM6si cells attenuated downstream IFN
signaling as indicated by a reduction of ISGF3 binding to the
MxA, OAS1, and ISG15 promoters in an electrophoretic mobility
shift assay (EMSA) (Figure 2G). These results indicate that TRIM6
is required for optimal signaling to induce IFN-b and ISGs during
viral infection or dsRNA stimulation.
TRIM6 also contributes to the establishment of an efficient
antiviral response against SeV (recognized by RIG-I) and
encephalomyocarditis virus (EMCV) (recognized by MDA5) (Fig-
ures 2H and 2I) in hDCs. At 6 hr p.i., IFN-b induction was sig-
nificantly reduced in TRIM6si cells as compared to controls
(Figure 2H, SeV p < 0.001, EMCV p < 0.003; Figure 2I), whereas
the levels of IL6 were not significantly affected (Figures 2H and
2I). SeV replication (assessed by gRNA real-time RT-PCR) was
significantly increased in three out of four donors (Figure 2I;
p < 0.001), whereas all four donors showed significant increase
in EMCV viral titers (Figures 2H and 2I; p < 0.001). These data
demonstrate that TRIM6 is critical for efficient IFN-b production
and establishment of an antiviral state in relevant primary human
cells.
TRIM6 Interacts through Its C-Terminal SPRY Domain
with IKKε
TRIM6 is required for optimal induction of IFN-b-dependent, but
not NF-kB-dependent, genes (Figures 1 and 2). We therefore
hypothesized that TRIM6 acts at the level of TBK-1, IKKε, or
IRF3 and investigated whether TRIM6 interacts with any of these
three candidates. Coimmunoprecipitation (coIP) studies demon-
strated that TRIM6 efficiently interacted with IKKε but not with
the closely related kinase TBK-1 or the transcription factor
IRF3 when coexpressed in HEK293T cells (Figure 3A), suggest-
ing that TRIM6may be required for IKKε activation. These results
were confirmed for endogenous TRIM6 and IKKε in primary
hDCs upon LPS stimulation, SeV infection, or IFN-b treatment
(Figure 3B).
Subsequently, confocal microscopy revealed that TRIM6
localizes in punctate cytoplasmic bodies as previously reported
(Reymond et al., 2001), whereas IKKε exhibits a diffuse locali-
zation throughout the cytoplasm (Figure 3C). However, upon
IKKε and TRIM6 coexpression, a substantial fraction of the total
IKKε colocalized with TRIM6 and thus appears to be recruited
to the cytoplasmic bodies where TRIM6 resides (Figure 3C).Immunity 40, 880–895, June 19, 2014 ª2014 Elsevier Inc. 881
Figure 1. TRIM6 Enhances Induction of IFN-b- but Not NF-kB-Dependent Cytokines
(A and B) HEK293T cells were transfected with the ISG54 IFN-stimulated responsive element (ISRE) or NF-kB reporter plasmid together with TRIM6 or
TRIM25 and stimulating plasmids or SeV as indicated, followed by luciferase assay. Data are representative of three independent experiments and depicted is
the mean ± SD (n = 3).
(C–E) hDCs transduced with lentiviruses expressing TRIM6 shRNAs were stimulated with LPS. At 2 hr p.t. cells were harvested for real-time RT-PCR and plotted
as percentage of control or fold induction over mock-induced samples.
See also Figure S1.
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colocalization increased upon IFN-b treatment and SeV infec-
tion, further substantiating the relevance of the IKKε-TRIM6
interaction in primary immune cells (Figure S3A).
To map the region of TRIM6 binding to IKKε, we generated
deletion mutants of TRIM6 expressing the RING domain, B box
domain, or the C-terminal SPRY domain (Figure 3D) and tested
interaction with IKKε by coIP. The C-terminal SPRY domain of
TRIM6 by itself specifically interacted with IKKε similar to full-
length TRIM6, whereas a mutant lacking only the SPRY domain882 Immunity 40, 880–895, June 19, 2014 ª2014 Elsevier Inc.lost the ability to interact with IKKε (Figure 3E). Furthermore, the
SPRY domain of TRIM6 interacted in vitro with baculovirus-pro-
duced recombinant IKKε protein (Figure S3B). Taken together,
these data indicate that TRIM6 interacts directly with IKKε
through its SPRY domain.
TRIM6 Is Critical for the Antiviral Response Mediated by
the IFN-b Signaling-IKKε Axis
Although IKKε has been implicated in the signaling pathway
to produce IFN-I, recent studies using IKKε-deficient mice
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pathway by inducing a subset of IKKε-dependent ISGs (Fig-
ure 4A; Perwitasari et al., 2011; Tenoever et al., 2007). Because
TRIM6 interacted with IKKε, we sought to determine the role of
TRIM6 in the IFN-I signaling pathway.
We first determined whether TRIM6 enhances the induction
of ISGs upon IFN treatment and whether IKKε is required for
this effect (Figure 4A). To test this, TRIM6 was exogenously
expressed in WT or Ikbke/ (the gene encoding IKKε) murine
embryonic fibroblasts (MEFs). TRIM6 overexpression effec-
tively enhanced the IFN-b-induced ISG54 promoter activity
in WT MEFs but not in Ikbke/ cells (Figure 4B). This activity
was not cell line specific as shown by the fact that TRIM6
was also able to enhance the IFN-b-induced ISG54 reporter
activity in Ddx58/ (the gene encoding RIG-I) MEFs (Fig-
ure 4B), which are attenuated only in their IFN induction,
but not signaling. These results demonstrate that TRIM6
specifically requires IKKε to induce ISGs. In line with these re-
sults, TRIM6si attenuated IKKε-dependent ISG54 and OAS1
mRNA expression upon IFN-b treatment, whereas IKKε-
independently regulated ISG15 and IRF7 mRNA expression
was not affected (Figure 4C). Moreover, depletion of TRIM6
enhanced IFN-g-mediated expression of ISGs (Figure S4A),
similar to the effects previously reported in Ikbke/ MEFs
(Ng et al., 2011).
As previously reported, IKKε underwent rapid activation by
autophosphorylation on T501 upon IFN-b treatment of control
A549 cells, which was impaired by TRIM6si (Figure 4D). In
contrast, phosphorylation of STAT1 on Y701 and STAT2 on
Y689 (which are IKKε independent) were unaffected by TRIM6si
(Figure 4D), indicating that TRIM6 is specifically required for
optimal IKKε activation but not for classic JAK1- and TYK2-
mediated activation of STATs. As expected, TBK1was not phos-
phorylated by IFN-b treatment and remained unaffected by
TRIM6si (Figure S4B).
IKKε has been previously shown to phosphorylate S708 on
STAT1, which is required for IKKε-dependent ISG induction (Fig-
ure 4A; Perwitasari et al., 2011; Tenoever et al., 2007). Consistent
with a role of TRIM6 on the IKKε-STAT1 arm of the IFN-signaling
pathway, IFN-induced S708 phosphorylation of STAT1 was
impaired in TRIM6-silenced hDCs. In contrast, IKKε-indepen-
dent STAT1-Y701 phosphorylation was not affected (Figure 4E).
Moreover, IKKε autophosporylation on T501 was also impaired
in TRIM6si hDCs (Figure 4E), which is in agreement with the
results in A549 cells (Figure 4D). An IKKε-dependent role for
TRIM6 was further substantiated by EMSA analysis, demon-
strating that TRIM6si attenuated ISGF3 binding to the ‘‘IKKε-
dependent’’ OAS1 promoter (Figure 4F).
We next determined the requirement of TRIM6 for conferring
biologically relevant IFN-mediated antiviral activity to virus
infection. TRIM6si in nonstimulated A549 cells only slightly
increased the replication IAV-expressing GFP (Figures 4G
and 4H). In contrast, TRIM6si attenuated antiviral activity of
IFN pretreatment, which resulted in a 3-fold increase in the
fraction of virus-infected cells (35%, Figures 4G and 4H).
Taken together, these results demonstrate that TRIM6 is
required for optimal activation of the IKKε branch of the IFN-
signaling pathway and is essential to establish an efficient anti-
viral state in cells.IKKε Interacts with K48-Linked Polyubiquitin Chains in
Cell Culture and In Vivo
TRIM6, like other TRIM family members, contains a RING
domain, which has been shown to confer E3-Ub ligase activity
(Meroni and Diez-Roux, 2005). Because we have shown that
TRIM6 is important for IKKε activity, we determined whether
TRIM6 is involved in ubiquitination of IKKε, the type of Ub linkage
it synthesizes, and whether this modification is important for
IKKε activity. To answer these questions, IKKε and different Ub
lysine mutants were exogenously expressed in the presence or
absence of TRIM6 and the levels of IKKε-associated Ub were
assessed by coIP. For these assays we used low amounts of
IKKε to avoid overactivation of the cells.
IKKε pulled down low levels of Ub in the absence of TRIM6
(Figure 5A, lane 4, IP). The amount of Ub that coIP with IKKε
was greatly enhanced by TRIM6 (Figure 5A, compare IP lanes
5 and 6 to lane 4), suggesting that TRIM6 synthesizes poly-Ub
forms that either covalently or noncovalently interact with IKKε.
These poly-Ub forms were predominantly K48 linked as shown
by the fact that coIP of a K48RUbmutant with IKKεwas reduced
as compared to other lysine mutants or WT Ub (Figure 5A,
compare IP lane 12 to other lanes). In fact, poly-Ub chains
formed exclusively through K48 linkage (all other lysinesmutated
to arginine) coIP more efficiently with IKKε as compared to WT-
Ub (Figure 5A, compare lane 14 to lane 6).
Importantly, poly-Ub chains did not coIP with IKKε in the pres-
ence of a TRIM6 mutant lacking the C-terminal SPRY domain
(Figure 5A, lane 15), which is required for TRIM6 binding to
IKKε (see Figure 3E), indicating that formation of a TRIM6-IKKε
complex is necessary for the IKKε-Ub interaction. Endogenous
K48-linked Ub chains also coIP with IKKε, which was abolished
in a TRIM6 E3 catalytic mutant (C15A; Figure 5B). In agreement,
the same RING mutant failed to enhance the IFN signaling
pathway (Figure 5C) or rescue ISRE reporter enhancement
upon TRIM6si (Figure 5D). In line with these exogenous expres-
sion studies, association of endogenous IKKε with K48-linked
poly-Ub chains increased upon IFN-b treatment in control
hDCs, whereas it was reduced in TRIM6si cells (Figure 5E).
Together, these results indicate that TRIM6 requires its E3 activ-
ity for IKKε-Ub association and enhancement of IFN signaling.
In an effort to ascertain that the TRIM6-IKKε-poly-Ub interac-
tion was physiologically relevant and occurs in vivo, we investi-
gated whether these three proteins interacted by coIP assays
in the lungs of mice treated with universal type I IFN (Figure 5F).
Intranasal (i.n.) IFN treatment resulted in rapid and transient
STAT1 phosphorylation at Y701 (WCE, 45 min–2 hr), followed
by STAT1 phosphorylation at S708 (WCE, 2–6 hr). Consistent
with the proposed role of IKKε in STAT1-S708 phosphorylation,
activation of IKKε (T501 phosphorylation) correlated with STAT1-
S708 phosphorylation. Consequently, coIP of poly-Ub chains
and TRIM6 with IKKε also correlated with IKKε-T501 and
STAT-S708 phosphorylation (Figure 5F).
To further demonstrate that TRIM6 is required for the forma-
tion of IKKε-Ub complexes and establisment of an efficient anti-
viral response in vivo, TRIM6 expression was silenced in the
lungs of mice via peptide-conjugated phosphorodiamidate mor-
pholino oligomers (PPMO) (Abes et al., 2006). In line with our re-
sults from hDCs and cell lines, the designed TRIM6 PPMOs effi-
ciently and specifically downregulated TRIM6 protein levels inImmunity 40, 880–895, June 19, 2014 ª2014 Elsevier Inc. 883
Figure 2. TRIM6 Is Required for Efficient Induction of IFN-b and ISGs
(A–G) A549 cells were transfected with a control or TRIM6-specific siRNAs.
(A–E) At 40 hr p.t., cells were mock-treated or infected with SeV (10 HAU/ml) (B and C, left; D, top), IAV (PR8; 2 PFU/cell) (B and C, right; D, bottom; E), or a
recombinant NS1 RNA binding mutant virus (R38A/K41A) (E).
(E) At 8 hr p.i. with IAV, cells were harvested for immunoblot (IB).
(F and G) At 40 hr p.t., cells were stimulated through MDA5 by transfection with dsRNA poly(I:C).
(F) At 8 hr p.t. with poly(I:C), cells were harvested for mRNA quantification by real-time RT-PCR.
(G) At 4 hr p.t. with poly(I:C), cells were harvested for EMSA analysis of ISGF3 binding to ISG promoters.
(legend continued on next page)
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Figure 3. IKKε Interacts with the C-Terminal SPRY Domain of TRIM6
(A)Whole-cell extracts (WCE) of HEK293T cells cotransfectedwith HA-TRIM6 and either GFP-IRF3, FLAG-IKKε, or TBK-1 were subjected to immunoprecipitation
(IP) with anti-HA beads.
(B) WCE of hDCs treated with SeV, LPS, or IFN-b were subjected to IP with IKKε antibody.
(C) Localization of HA-TRIM6 and FLAG-IKKε in HeLa cells determined by confocal microscopy.
(D) TRIM6 deletion mutants used for coIP.
(E) GST pull down of HEK293T cells transfected with GST-TRIM deletion mutants and FLAG-IKKε.
See also Figure S3.
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IFN-b treatement (Figure S5A). To test the effects of PPMO-
mediated TRIM6si in vivo, we first determined the kinetics of
IAV infection in vivo. Mice not treated with PPMO were infected
i.n. with IAV for up to 5 days and analyzed for TRIM6, IKKε, and
poly-Ub interaction in their lungs by coIP at different times p.i.
(Figure S5B). Viral loads peaked at 3 days p.i. and remained
high until 5 days p.i. (Figure S5C). Viral replication in the lungs
of infected mice correlated with increased mRNA levels of M1(H) hDCs transduced with lentiviruses expressing TRIM6 shRNAs were infected w
or at 24 hr p.i. for virus titration by real-time RT-PCR or plaque assay. Values are
(I) The effect of knockdown for all four donors combined was determined by two
See also Figure S2.viral RNA, IFN-b, TRIM6, and the IFN-stimulated gene ADAR1
(Figure S5D). The protein levels of TRIM6, Ub, and IKKε
increased in the lungs of infected mice as compared with con-
trols (Figure S5E, WCE). Furthermore, IKKε interaction with
TRIM6 and Ub was detected as early as 1 day p.i. and increased
in a time-dependent manner (Figure S5E, IP).
We next assessed the effects of PPMO-mediated TRIM6si on
viral load, cytokine and ISG induction, and IKKε-Ub association
at early time points p.i., before the peak level of viral titer isith SeV or EMCV. Cells were harvested at 6 hr p.i. for real-time RT-PCR analysis
plotted as fold induction over mock samples. Data represent mean ± SD.
-way ANOVA. **p < 0.01; ***p < 0.001; N.S., not significant.
Immunity 40, 880–895, June 19, 2014 ª2014 Elsevier Inc. 885
(legend on next page)
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Treatment with PPMOs resulted in 50% reduction in TRIM6
mRNA and protein compared to nontargeting PPMO control in
the lungs of infected and noninfected mice (Figure 5H, WCE
and S5G). Reduction in TRIM6 expression in the lungs of mice
correlated with increased viral load, as assessed by plaque
assay (Figure 5G), real-time RT-PCR for viral M1 mRNA (Fig-
ure S5G), and immunoblot for viral nucleoprotein (NP) and
NS1 protein (Figure 5H, WCE). The effects of TRIM6 silencing
mirrored the phenotype previously observed in Ikbke/ mice
upon IAV infection (Tenoever et al., 2007). Namely, although
the levels of IFN-b mRNA were higher in the lungs of TRIM6-
silenced mice, induction of the IKKε-dependent ISGs ADAR1
and IFI44 was reduced as compared to controls (Figure S5G),
consistent with defective IFN-I signaling. In contrast, the induc-
tion of proinflammatory cytokines TNF-a and IL-6 as well as IL-
12p40 (Figure S5G) was unaffected, indicating that TRIM6
silencing in vivo specifically affects the IFN-I-IKKε axis, consis-
tent with our observations in human DCs.
Importantly, the formation of IKKε-Ub complexes and IKKε
autophosphorylation were reduced in TRIM6si lungs as com-
pared to controls (Figures 5H and S5H), indicating that TRIM6
is required for IKKε activation in vivo. In support of this,
STAT1-S708 phosphorylation was also reduced in TRIM6si lungs
(Figure 5H, WCE). In contrast, STAT1 induction (an IKKε-inde-
pendent ISG) and STAT1-Y701 phosphorylation (which is IKKε
independent) were not affected in TRIM6si lungs (Figure 5H,
WCE) indicating that TRIM6 specifically acts in the IKKε axis of
the IFN-I signaling in vivo and confirms our results obtained in
cell lines and human DCs.
Taken together, these data indicate that TRIM6 facilitates Ub
chain synthesis required for efficient IKKε function in IFN-I
signaling and demonstrate that TRIM6 is required for establish-
ment of an efficient antiviral response in cultured cells and
in vivo.
TRIM6 Facilitates the Synthesis of Unanchored
Ubiquitin Chains that Interact with IKKε and Are
Required for Efficient Type I IFN Signaling
The previous analyses did not determine whether IKKε is cova-
lently modified by Ub or whether it interacts noncovalently with
ubiquitinated proteins or unanchored Ub chains. Furthermore,
previous studies have also foundUb associated with IKKε (Fried-
man et al., 2008; Parvatiyar et al., 2010) but did not address
whether these Ub chains were unanchored or covalently
attached. To distinguish between these possibilities, a dena-
turing pull-down analysis of his-tagged Ub coexpressed with
IKKε was performed (Figure S6A). In contrast to the resultsFigure 4. TRIM6 Is Critical for the Antiviral Response Mediated by the
(A) Schematics of the IFN-mediated IKKε-dependent and IKKε-independent sign
(B) WT, Ikbke/, or Ddx58/ MEFs were transfected with ISG54 luciferase repo
were stimulated with IFN-b (100 U/ml) for 16 hr, followed by luciferase assay. Data
mean ± SD (n = 3).
(C, D, F–H) A549 cells were tranfected with TRIM6 siRNAs followed by stimulatio
(C, D, and F) Cells were harvested for (C) real-time RT-PCR analysis of ISG mRN
(E) hDCs transduced with lentiviruses expressing TRIM6 shRNAs were stimulate
(G and H) A549 cells were transfected with TRIM6 siRNAs for 40 hr and subseque
expressing GFP (PR8-GFP) for 16 hr. Cells were visualized by fluorescence micr
*p < 0.05; **p < 0.01; ***p < 0.001, N.S. (not significant). See also Figure S4.from the above-described coIP under native conditions, we did
not detect ubiquitinated IKKε under denaturing pull-down condi-
tions (Figure 6A), whereas ubiquitinated TRIM6 was readily
detected, confirming the validity of the assay. Also, higher-
migrating—potentially ubiquitinated—forms of IKKεwere not de-
tected in the WCE (Figure 6A). Together, these data suggested
that IKKε might interact noncovalently with TRIM6-synthesized
unattached poly-Ub chains or other TRIM6-ubiquitinated cellular
proteins.
Because unanchored K63 Ub chains have recently been
recognized as significant signaling mediators (Pertel et al.,
2011; Xia et al., 2009; Zeng et al., 2010), we set out to determine
whether the TRIM6-synthesized Ub moieties interacting with
IKKε were in fact unanchored Ub chains. To this end we utilized
coexpression of isopeptidase T/USP5 (IsoT), which has been
well established to specifically degrade unanchored Ub through
recognition of its exposed C-terminal diglycine residues while
not deconjugating attached Ub chains (Figure S6B; Reyes-Turcu
et al., 2006; Zeng et al., 2010). Indeed, in agreement with our
hypothesis, coexpression of IsoT decreased the amount of
TRIM6-synthesized multimeric Ub interacting with IKKε in a
dose-dependent manner (Figure 6B, left). Likewise, treatment
of isolated IKKε-Ub complexes with recombinant IsoT in vitro
also reduced the amount of poly-Ub chains that coIP with IKKε
(Figure S6C). In contrast, IsoT expression did not have a major
effect on multimeric Ub coimmunoprecipitated with JAK1, which
was used as a control (Figure 6B, right). This suggests that
JAK1-associated Ub chains are primarily covalently attached,
whereas the poly-Ub chains associated with IKKε are unan-
chored and their synthesis is mediated by TRIM6.
Furthermore, IsoT coexpression reduced the TRIM6-depen-
dent ISG54 reporter activation almost to the level of the control
without TRIM6 (Figures 6C and 6D), suggesting that unanchored
Ub chains are important for TRIM6-dependent IKKε enhance-
ment. In agreement, cleavage of both anchored and unanchored
poly-Ub chains by coexpression of the ovarian tumor (OTU)
domain of Crimean Congo hemorrhagic fever virus (CCHFV)
large (L) protein (Frias-Staheli et al., 2007) also negated
TRIM6-mediated IKKε activation of the ISG54 promoter (Fig-
ure 6D). In contrast, a noncatalytic control mutant lacking this
activity did not (Figure 6D).
We next determined whether the formation of the IKKε-Ub
complex in vivo requires IFN signaling during infection and
whether the Ub chains formed in vivo are indeed unanchored.
To this end, WT and Ifnar1/ mice were infected i.n. with IAV
for up to 5 days; theywere analyzed for IKKε and poly-Ub interac-
tion in their lungs by coIP at different times p.i. In agreement with
the results decribed above, K48-linked poly-Ub chains andIFN-b and IKKε Axis
aling for ISG induction.
rter plasmid together with empty vector or TRIM6 plasmid. At 24 hr p.t., cells
shown are representative of three independent experiments and depicted is the
n with IFN-b (100 U/ml).
A, (D) IB, or (F) EMSA analysis.
d with IFN-b (100 U/ml) and subjected to IB.
ntly pretreated with IFN-b (100 U/ml) for 16 hr. Cells were then infected with IAV
oscopy (G) and quantified by FACS (H).
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virus-infected WT mice, but not Ifnar1/ mice, indicating that
the formation of this complex is IFN-I signaling dependent (Fig-
ure S6D). Importantly, the poly-Ub chains bound to IKKε in WT
mice were unanchored as indicated by the fact that they were
degradedby invitro treatmentwith recombinant IsoT (FigureS6D;
compare ‘‘day 3WT’’ in lane 4 with ‘‘day 3WT + IsoT’’ in lane 11).
Finally, to demonstrate that IKKε interacts directly with unan-
chored K48-linked Ub chains, a cell-free system with baculovi-
rus-expressed recombinant IKKε purified from insect cells was
established and used to determine IKKε binding to recombinant
Ub chains in vitro (Figure S6E). IKKε interacted with K48-linked
(lanes 9–10) but not K63-linked (lane 11) poly-Ub or K48-K63
mixed-linkage tetra-Ub (lane 12). Binding of IKKε to Ub required
a minimum of four Ub units as shown by the fact that di- or tri-Ub
did not coimmunoprecipitate with IKKε under these conditions
(Figure S6E).
Taken together, these results show that (1) IKKε interacts
directly with unanchored K48-linked poly-Ub chains, (2) TRIM6
enhances IKKε interaction with these unanchored K48-linked
Ub chains, and (3) these Ub chains are important for TRIM6-
IKKε-dependent ISG induction.
IKKε Is Recruited to TRIM6-Ubiquitin-Rich Bodies
Next, by confocal microscopy we addressed whether TRIM6
and IKKε colocalize with Ub in the cell. TRIM6 localized into
defined cytoplasmic dots (Figure 6E), in agreement with previous
findings (Figure 3C; Reymond et al., 2001). Exogenously ex-
pressedUb alone exhibited weak staining distributed throughout
the cell. This Ub staining increased when coexpressed with
TRIM6 and extensively colocalized with the punctate cyto-
plasmic TRIM6 bodies (Figure 6E). Similarly, IKKε alone localized
diffusely throughout the cytoplasm (Figures 6F and 3C) and relo-
calized into the same compartment as both TRIM6 and Ub upon
coexpression of TRIM6 (Figure 6F).
Exogenous IsoT expression disrupted the TRIM6 punctate
structures, without affecting TRIM6-IKKε colocalization (Fig-
ure S6F), as well as in vitro treatment with IsoT specifically
degraded the unanchored poly-Ub chains associated with
TRIM6, while not having an effect on covalently ubiquitinated
TRIM25 used as a control (Figure S6G). Together these data sug-
gest that unanchored Ub chains are essential for the formation of
cytoplasmic ‘‘TRIM-Ub-rich bodies’’ but not for TRIM6-IKKε
interaction. They indicate that (1) TRIM6 enhances the synthesis
of Ub forms in defined subcellular structures and (2) IKKε inter-
acts with TRIM6 and requires TRIM6-mediated Ub synthesis
for its activity.Figure 5. IKKε Interacts with K48-Linked Polyubiquitin Chains Synthes
(A and B) HEK293T cells were transfected with FLAG-IKKε together with HA-Ub W
or GST-RBCC (TRIM6 lacking SPRY domain, lane 15) (A) or FLAG-IKKεwith HA-TR
(C and D) Luciferase assay of HEK293T cells transfected with ISG54 reporter tog
tranfected with TRIM6 siRNA followed by transfection with ISG54 reporter and T
mean ± SD (n = 3).
(E) hDCs transduced with lentiviruses expressing TRIM6 shRNAs were stimulate
(F) BALB/c mice were treated i.n. with 12,000 units of universal IFN. Lungs were
(G and H) Silencing of TRIM6 in vivo. BALB/c mice were treated i.n. with TRIM6-ta
IAV PR8. Lungs were collected for virus titer (G), depicted is the mean ± SD (n =
See also Figure S5.TRIM6 and the E2 Conjugase UbE2K Cooperatively
Synthesize Unanchored K48-Linked Ubiquitin Chains
Required for IKKε Activation
To demonstrate that TRIM6 can synthesize K48-Ub chains
directly mediating IKKε activation, a TRIM6 in vitro ubiquitination
assay was established. Ub conjugation requires the activity
of E1-activating, E2-conjugating, and E3-ligating enzymes.
Because the E2 enzyme that couples TRIM6 to Ub conjugation
had yet to be determined, first an in vitro screen with 29 common
E2 ligases was performed for their ability to synthesize poly-Ub
chains in the presence of TRIM6.
By these means we identified three E2 enzymes (UbE2K,
CDC34, Ube2G2; data not shown) previously reported to facili-
tate K48-linked Ub chain synthesis (Chen and Pickart, 1990; Pet-
roski and Deshaies, 2005; Shin et al., 2011), which were tested in
knockdown experiments for their requirement in IFN-b-depen-
dent ISG induction. Only UbE2K silencing in A549 cells resulted
in a decrease of ISG54 mRNA induction upon IFN stimulation as
compared to control cells (Figure 7A). In contrast, silencing of
CDC34 or UbE2G2 did not attenuate ISG54 mRNA induction,
or even increased it (Figure 7A), despite similar knockdown
(>80%; data not shown).
The UbE2K conjugase is known to elongate mono-Ub to pro-
duce K48-linked poly-Ub chains (Wilson et al., 2011) and has
been reported to have the ability to synthesize unanchored
poly-Ub chains in the absence of an E3 ligase in vitro (Chen
and Pickart, 1990). Thus, as anticipated, K48-linked poly-Ub
chains were produced in a UbE2K dose-dependent manner (Fig-
ure 7B). Under these conditions (at high concentrations of
UbE2K and high amounts of synthesized K48 poly-Ub), IKKε au-
tophosphorylation was detected on T501 (Figure 7B), demon-
strating that UbE2K can mediate K48 Ub chain synthesis and
IKKε activation. Moreover, K48-linked poly-Ub chain production
and IKKε activation by the lowest concentration of UbE2K
(0.025 mM) were enhanced by TRIM6 in a dose-dependent
manner (Figure 7C), indicating that TRIM6 in combination with
UbE2K acts as an E3 ligase driving the synthesis of K48 polyubi-
quitin. IKKε autophosphorylation was specific as shown by the
fact that T501 was not phosphorylated in the presence of an
inactive IKKε kinase mutant (K38A; Figure S7A). As expected,
poly-Ub synthesis was completely dependent on ATP and the
presence of UbE2K, but not IKKε (Figure 7C). In addition, these
poly-Ub chains were exclusively K48 linked as indicated by the
fact that they were not produced from a K48R mono-Ub mutant
substrate (Figure S7A). Conversely, chain synthesis of a Ub
mutant with all lysines mutated except for K48 (K48only) was
enhanced.ized by TRIM6
T (lanes 1–2, 4–6, 15) or different Ub mutants and with GST-TRIM6 (lane 6–14)
IM6 or TRIM6 C15ARINGmutant (B). IP was performedwith anti-FLAG beads.
ether with TRIM6 WT or C15A mutant, and treated with IFN-b (100 U/ml) (C) or
RIM6 plasmids and IFN-b treatment (100 U/ml) (D) 24 hr later. Depicted is the
d with IFN-b (100 U/ml) and subjected to IKKε IP.
collected and IKKε IP was performed.
rgeting or nontargeting PPMO at 24 and 48 hr prior to i.n. infection with 100 pfu
3), or at 48 hr p.i. for IKKε IP (H).
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poly-Ub chains, after which IKKε activation was determined.
Only a mixture of K48-linked poly-Ub chains (2–7 Ub mole-
cules/chain) activated IKKε T501 autophosphorylation in a
dose-dependent manner; similar amounts of K63-linked chains
did not (Figure 7D). This further demonstrates that specifically
K48-linked poly-Ub chains—such as synthesized by UbE2K
and TRIM6—activate IKKε.
We next confirmed that K48 poly-Ub-activated IKKε has
indeed increased kinase activity toward its bona fide target
STAT1. K48- but not K63-linked poly-Ub chains reproducibly
increased purified STAT1 phosphorylation by IKKε in a dose-
dependent manner (Figure 7E). Importantly, longer K48-linked
poly-Ub chains (mixture of 2–16 Ubs/chain), which putatively
more closely resemble the high-molecular forms of Ub found
in vivo (Figure 5F, S5E, and S6D), induced even higher
levels of STAT1 phosphorylation, as well as increased IKKε
autophosphorylation (Figure 7F). Again, this was specific to
IKKε; no phosphorylation was detected with the IKKε K38A
mutant.
These results were substantiated by investigating whether
isolated TRIM6-synthesized endogenous, unanchored poly-Ub
chains could facilitate IKKε-dependent phosphorylation of
STAT1 in vitro. To this end, endogenous Ub chains bound to
IKKεwere isolated as previously described for RIG-I (Figure S7B;
Zeng et al., 2010). In agreement with our other data, Ub chains
isolated from IKKε alone limitedly increased STAT1 phosphoryla-
tion (Figure 7G, compare lanes 1 and 2). Strikingly, endogenous
Ub chains isolated from IKKε expressed in the presence of
TRIM6 even further enhanced IKKε-dependent STAT1 phos-
phorylation within the limited experimental window (Figure 7G,
compare lanes 2 and 4). Moreover, the poly-Ub-mediated in-
crease in STAT1 phosphorylation was abrogated upon IsoT
treatment, confirming that the enhancement of STAT1 phos-
phorylation depends on unanchored poly-Ub chains (Figure 7G,
compare lanes 2 with 3 and 4 with 5).
Finally, to better understand the mechanism of IKKε activation
by TRIM6 and poly-Ub chains, we mapped the region of IKKε
required for interaction with TRIM6 and Ub by coIP using trun-
cated forms of IKKε (Figure S7C). TRIM6 and poly-Ub chains
interacted more efficiently with the kinase domain and IKKε
mutants lacking their C-terminal CCDs (Figure S7D). However,
TRIM6 interacted less efficiently with a shorter form of IKKε
expressing both the kinase domain and the Ub-like domain
(UBLD), suggesting that the UBLD could fold back on the kinase
domain as previously reported (Ikeda et al., 2007), thereby inter-
fering with TRIM6 binding to the IKKε kinase domain. Further-Figure 6. IKKε Interacts with Unanchored Polyubiquitin Chains Synthe
(A) HEK293T cells, transfected with FLAG-IKKε plasmid together with empty ve
denaturing conditions.
(B) HEK293T cells were transfected with empty vector or FLAG-IKKε together w
(IsoT), which cleaves only unanchored Ub. At 30 hr p.t., IP with anti-FLAG antibod
cleave (right side).
(C and D) ISG54 reporter assay of HEK293T cells transfected with IKKε and TRIM
OTU domain of the CCHFV, or a mutant (C40A and H151A) lacking catalytic act
independent experiments (mean ± SD, n = 3).
(E and F) IKKε is recruited to ‘‘TRIM6 Ub-rich bodies.’’ Confocal microscopy of He
IKKε, and His-Ub (F).
See also Figure S6.more, residue S172 in the IKKε kinase domain was critical for
interaction with TRIM6 and Ub (Figure S7D, last lane). In line
with these observations, the IKKε S172A mutant did not activate
the ISG54 promoter in a reporter assay (Figure S7E). In addition,
TRIM6 did not enhance the IKKε S172A-dependent ISG54 re-
porter activity as compared to TRIM6 alone or WT-IKKε alone
(Figure S7F).
Because unanchored K48 Ub chains induced transactivation
of IKKε (Figure 7D), we hypothezised that TRIM6-synthesized
poly-Ub chains are important for IKKε oligomerization and thus
transactivation by binding to the kinase domain of IKKε. In line
with this hypothesis, in vitro data indicated that IKKε runs as a
dimer under native conditions (Figure S7G) and addition of
K48-linked poly-Ub chains increased the oligomerization of
IKKε, with the strongest effect obtained in the presence of long
K48-linked poly-Ub chains (Figure S7G). Thus, K48-linked
poly-Ub chains promote oligomerization of IKKε, suggesting
that oligomerization is important for transactivation.
TRIM6 Interacts with the JAK1 Kinase
It remains to be determined how TRIM6 itself is regulated at the
detailed molecular level. A possible mechanism could entail
direct TRIM6 activation by the JAK1 and TYK2 kinases down-
stream of the IFN-I receptor. In support of this possibility,
JAK1 interacted with TRIM6 and induced TRIM6 tyrosine phos-
phorylation (Figures S7H and S7I). Although the nature of this
TRIM6 phosphorylated form remains to be determined, it is
tempting to speculate that TRIM6 may be activated by JAK1
after IFN treatment.
Taken together, our results demonstrate that TRIM6 and
UbE2K cooperate in the synthesis of K48-linked unanchored
poly-Ub chains, which activate IKKε for STAT1 phosphorylation
(Figure S7J). The IKKε-targeted phosphorylation site on STAT1
(S708) promotes antiviral activity through induction of a subset
of ISGs. This phosphorylation is distinct from IKKε-independent
STAT1-Y701 phosphorylation mediated by JAK1 and TYK2,
which drives IKKε-independent ISG expression (Figure S7J).
DISCUSSION
In this study we demonstrate that the Ub E3 ligase TRIM6 is
required for efficient IFN-I signaling and establishment of an anti-
viral state by synthesis of K48-linked unanchored poly-Ub
chains, which activate IKKε for STAT1 phosphorylation. Our find-
ings indicate that these Ub chains play a role in both whole-cell
context and in vivo. This is supported by four lines of evidence:
(1) expression of IsoT, which specifically degrades unanchoredsized by TRIM6
ctor or HA-TRIM6 and His-tagged Ub, were subjected to His-pulldown under
ith HA-Ub and GST-TRIM6 in the presence or absence of the isopeptidase T
y. FLAG-JAK1 was used as a control of covalently bound Ub that IsoT cannot
6 in the presence or absence of IsoT (C), or in the presence or absence of IsoT,
ivity (D), followed by IFN-b treatment. Data shown are representative of three
La cells transfected with HA-TRIM6 and FLAG-Ub (E) or with HA-TRIM6, FLAG-
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Figure 7. The E2-Ligase UbE2K and TRIM6 Catalyze K48-Linked Ubiquitin Chains that Activate IKKε for STAT1 Phosphorylation In Vitro
(A) Knockdown of endogenous E2 conjugases UbE2K, CDC34, and UbE2G2 in A549 cells. At 40 hr p.t., cells were mock-treated or stimulated with IFN-b
(500 U/ml) for 3 hr and cells were harvested for real-time RT-PCR analysis. Values are depicted as fold induction over nonstimulated cells.
(B) Purified FLAG-IKKε was incubated with recombinant E1, UbE2K (0.025–0.5 mM), mono-Ub, and ATP. Activation of IKKε was assessed by phophorylation
of T501.
(C) Increasing amounts of TRIM6 were added to limiting amounts of UbE2K (0.025 mM).
(D) Recombinant K48- or K63-linked poly-Ub chains (2–7 Ub molecules/chain) were incubated with FLAG-IKKε and subjected to IB analysis.
(E and F) In vitro STAT1 kinase assay. Recombinant K48- or K63-linked poly-Ub chains (2–7 Ub/chain in E or K48 2–16 Ub/chain in F) were incubated with purified
IKKε WT (E and F) or an IKKε kinase-dead mutant (K38A in F) STAT1 and g-[32]ATP. The reaction mixture was subjected to SDS-PAGE and visualized by
autoradiography. The bands were quantified with ImageJ software.
(G) Endogenous unanchored poly-Ub chains induce IKKε-mediated STAT1 phosphorylation.WCE of HEK293T cells, transfected with FLAG-IKKε andHA-TRIM6,
were subjected to FLAG-IP. Poly-Ub chains bound to IKKε were isolated by incubation at 75C for 5 min, followed by treatment with IsoT. These Ub chains were
used for IKKε-mediated STAT1 kinase assay. The bands were quantified with ImageJ software, normalized by the input (Coomassie), and expressed as per-
centage of control without Ub chains. The quantification data are from two independent experiments.
See also Figure S7.
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of the E2-Ub ligase Ube2K, which is known to synthesize K48-
linked poly-Ub chains (Chen and Pickart, 1990; Wilson et al.,892 Immunity 40, 880–895, June 19, 2014 ª2014 Elsevier Inc.2011), attenuated ISG expression upon IFN stimulation; (3)
poly-Ub chains interact with IKKε in mouse lungs during viral
infection in an IFN-I-dependent manner; and (4) the formation
Immunity
TRIM6 Regulates the Type I IFN Systemof IKKε-Ub complexes is reduced in TRIM6si mouse lungs upon
viral infection.
Importantly, TRIM6si not only impaired IFN signaling but also
impaired IFN-b production upon TLR and RLR stimulation in pri-
mary human DCs and human cell lines, although this was not the
case in the lungs of IAV-infected mice. One possible explanation
for this discrepancy could be differences in TRIM6 function in hu-
man and mouse. Alternatively, TRIM6 may have cell-type-spe-
cific effects or may act at multiple levels in signaling pathways
of the IFN-I system. Moreover, increased IFN production in
TRIM6si mice may be a reflection of increased viral replication
as a result of diminished antiviral response. In addition, any
defect on IFN production in TRIM6si cells in the lung may have
been obscured by IFN produced from other cells in the lung
that were not subject to TRIM6si, as, for example, infiltrating
cells.
Although it is clear that IKKε phosphorylates IRF3 and IRF7 for
IFN induction (Sharma et al., 2003), production of IFN-I was not
reduced in Ikbke/ mice upon IAV infection (Tenoever et al.,
2007). However, studies have suggested that TBK-1 and IKKε
play a redundant role in IFN induction (Hemmi et al., 2004).
Therefore it is still plausible that TRIM6 may also play a role by
activating IKKε for IFN-b production in specific cell types or
under specific conditions. Alternatively, TRIM6 may have other
signaling partners in addition to IKKε for IFN induction, as it
has been shown for other TRIMs (Rajsbaum et al., 2014). The
specific role of TRIM6 in the IFN-b induction pathway will need
to be determined in future studies.
In our immunofluorescence experiments, TRIM6, IKKε, andUb
colocalized in punctate cytoplasmic bodies. These structures,
which have also been observed for other TRIMs, seem to be
independent subcellular compartments because they do not
colocalize with any markers for known cellular structures (Rey-
mond et al., 2001). Because we observed a dramatic increase
in Ub staining in these TRIM6-containing bodies, we speculate
that these structures may be ‘‘Ub factories’’ whereto other target
proteins—such as IKKε—can be recruited during signaling.
These structures required an intact TRIM6 coiled-coil region
(data not shown; Reymond et al., 2001) and formation of poly-
Ub chains by TRIM6, suggesting that oligomerization is essential
for their assembly. These subcellular structures may be an
important compartmentalization mechanism in the cell.
Our data suggest that TRIM6 could be activated upon IFN
stimulation by the JAK1 kinase by binding and phosphorylating
TRIM6. However, TRIM6 activation may also involve ubiquitina-
tion by a yet unidentified E3-ligase because covalent K63-linked
ubiquitination of both WT TRIM6 and its E3 ligase C15A mutant
was detected.
In conclusion, our study identified TRIM6, UbE2K, and K48-
linked poly-Ub chains as players critical for the IKKε branch of
the IFN-I signaling pathway and subsequent establishment of a
protective antiviral response. Our study provides a framework
for future work on the TRIM family of proteins, as well as the
mechanism of kinase activation by unanchored K48-linked
poly-Ub chains related to antiviral immunity. Although we report
a unique function of unanchored K48-poly-Ub in kinase activa-
tion, it might be possible that thesemolecules participate in other
signaling processes also, as is the case for unanchored K63-
poly-Ub (Pertel et al., 2011; Xia et al., 2009; Zeng et al., 2010).Free poly-Ub is therefore emerging as a secondary messenger
that participates in regulation of signaling and further studies
are needed to fully elucidate cellular processes that are
controlled by the synthesis of unanchored Ub chains.
EXPERIMENTAL PROCEDURES
In Vitro Ubiquitination Assay and Activation of IKKε
Ubiquitination assays in vitro were performed with the Ub conjugation initia-
tion kit (Boston Biochem). In brief, a mix was prepared containing the E1
enzyme, Ub, and reaction buffer in the presence or absence of the E2 ligase
UbE2K (Boston Biochem) (0.02–0.5 mM) and the presence or absence of
FLAG-purified IKKε (0.1 ml) and HA-TRIM6 purified from HEK293T cells
with HA-beads (0.05–0.5 ml). The reaction was initiated with addition of
1 mM Mg-ATP and stopped after 1 hr at 30C by addition of Laemmli sample
buffer (BioRad) containing b-mercaproethanol and boiled for 5 min. Poly-Ub
and IKKε autophosphorylation was detected by IB with a-pIKKε(T501)
(Novus Biologicals).
Isolation and Analysis of Endogenous Polyubiquitin Chains
We followed a previously described protocol used by Zeng et al. (2010)
to isolate chains from RIG-I(2CARD). For details, see Supplemental
Information.
siRNA-Mediated Gene Targeting
Transient gene targeting of endogenous TRIM6 in A549 or HEK293T cells,
seeded in 24-well plates (30,000 cell/well), was achieved by transfection of
10 picomol of nontargeting control or an siRNA specific for TRIM6 (see Supple-
mental Information for sequences) with RNAiMAX (Invitrogen) according to the
manufacturer’s instructions.
TRIM6 Gene Targeting in Human DCs with shRNA Lentiviral Vectors
Peripheral blood mononuclear cells were isolated from buffy coats of healthy
human donors by Ficoll density gradient centrifugation (Histopaque, Sigma
Aldrich) as previously described (Fernandez-Sesma et al., 2006). For additional
details see Supplemental Information. All human research protocols for this
work have been reviewed and approved by the Institutional Review Board of
the Mount Sinai School of Medicine.
In Vitro Oligomerization Assay and Native PAGE
Purified FLAG-IKKε protein was incubated with Ub chains in the presence or
absence of 1 mM of ATP and 2 mM MgCl2 in 50 mM Tris, 150 mM NaCl,
1mMDTT buffer at 37C for 15min to allow formation of complexes. Reactions
were stopped by addition of 13 Native PAGE sample buffer (Life) and sub-
jected to native PAGE on a 3%–12% Bis-Tris gel (Life), transferred to PVDF
membranes, fixed with 8% acetic acid in H2O, and immunoblotting was per-
formed with anti-FLAG antibodies.
TRIM6 Gene Targeting In Vivo by PPMOs
The peptide-conjugated phosphorodiamidate morpholino oligomers (PPMO)
were produced by previously publishedmethods (Abes et al., 2006). All mouse
experiments were carried out in accordance with Institutional Animal Care and
Use Committee (IACUC) guidelines and have been approved by the IACUC of
Icahn School of Medicine at Mount Sinai. BALB/c mice were anesthetized with
ketamine, followed by i.n. administration with 100 mg (approximately 5 mg/kg)
PPMO (in 40 ml of PBS). After 24 hr, PPMO treatment was repeated. At 48 hr
after the first PPMO administration, mice were infected i.n. with 1,000 PFU
of influenza virus (strain A/Puerto Rico/8/1934 H1N1 [PR8]). At 24 and 48 hr
p.i., mice were euthanized and the lungs were collected and divided into 3
equivalent portions, followed by homogenization and subsequent plaque
assay, real-time PCR analysis, and coIP studies. For more details see Supple-
mental Information.
Statistical Analysis
Statistical analysis was performed with Prism (Version 5.0, GraphPad Soft-
ware). Student’s paired t test or in defined cases two-way ANOVAwith Bonfer-
roni post-test were used. *p < 0.05; **p < 0.01; ***p < 0.001.Immunity 40, 880–895, June 19, 2014 ª2014 Elsevier Inc. 893
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